Century Therapeutics Inc

According to Century Therapeutics Inc's FY2025 earnings report, its total revenue reached 109.16M, with a year-on-year change of 1556.76.

According to Century Therapeutics Inc's FY2025 earnings report, its current assets were 120.77M, with a year-on-year change of -37.76.

According to Century Therapeutics Inc's FY2025 earnings report, its total assets of Century Therapeutics Inc were 223.70M, with a year-on-year change of -36.67.

According to Century Therapeutics Inc's FY2025 earnings report, its total liabilities of Century Therapeutics Inc were 64.77M, with a year-on-year change of -66.24.

According to Century Therapeutics Inc's FY2025 earnings report, its total equity of Century Therapeutics Inc was 158.94M, with a year-on-year change of -1.50.

According to Century Therapeutics Inc's FY2025 earnings report, its net investment of Century Therapeutics Inc was 107.50M, with a year-on-year change of 126.40.

According to Century Therapeutics Inc's FY2025 earnings report, its net financing of Century Therapeutics Inc was 173.00K, with a year-on-year change of -99.77.

According to Century Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.11, with a year-on-year change of 93.12.

According to Century Therapeutics Inc's FY2025 earnings report, its net profit margin was -8.78, with a year-on-year change of 99.54.

According to Century Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -5.98, with a year-on-year change of 91.82.

According to Century Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -3.32, with a year-on-year change of 90.63.

According to Century Therapeutics Inc's FY2025 earnings report, its operating profit was -10.51M, with a year-on-year change of 92.15.